Bruce Frederick Israel, MD | |
53 S French Broad Ave, Ste 200, Asheville, NC 28801-3272 | |
(828) 258-9635 | |
(828) 258-9682 |
Full Name | Bruce Frederick Israel |
---|---|
Gender | Male |
Speciality | Infectious Disease |
Experience | 29 Years |
Location | 53 S French Broad Ave, Asheville, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194775098 | NPI | - | NPPES |
1202V | Other | NC | BCBS |
891202V | Medicaid | NC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RI0200X | Internal Medicine - Infectious Disease | 9800916 (North Carolina) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Memorial Mission Hospital And Asheville Surgery Ce | Asheville, NC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mission Health Community Multispecialty Providers Llc | 9537468574 | 577 |
News Archive
The U.S. Food and Drug Administration today approved the first genetic test that can help some colorectal cancer (CRC) patients and their doctors determine if the drug Erbitux (cetuximab) would be an effective treatment based on the absence of a gene mutation. The therascreen KRAS RGQ PCR Kit can provide information about the KRAS gene mutation in patients whose CRC has spread to other parts of their body (metastasized).
Atherosclerotic narrowing and hardening of coronary arteries typically appear first at vessel branches, and a study in the October issue of Cellular Signalling reports that the type of mechanical stretching found at those branches activates a cellular protein known to damage cells.
A specific gene region has long been suspected of contributing to obesity in humans but the precise mechanisms behind this were previously unclear. Now, researchers at the Technical University of Munich (TUM), Massachusetts Institute of Technology (MIT), Harvard Medical School and other partners have been able to show that a single genetic alteration in this region reduces thermogenesis (fat burning), instead increasing lipid storage.
Pharmacyclics, Inc. today reported financial results and recent developments for the quarter and year ended December 31, 2013.
The East Tennessee Health Information Network (etHIN) has selected OptumInsight's health information exchange (HIE) technology to help physicians, hospitals and other health care providers in the region improve patient care coordination and quality.
› Verified 9 days ago
Entity Name | Mission Health Community Multispecialty Providers Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457719130 PECOS PAC ID: 9537468574 Enrollment ID: O20160426001883 |
News Archive
The U.S. Food and Drug Administration today approved the first genetic test that can help some colorectal cancer (CRC) patients and their doctors determine if the drug Erbitux (cetuximab) would be an effective treatment based on the absence of a gene mutation. The therascreen KRAS RGQ PCR Kit can provide information about the KRAS gene mutation in patients whose CRC has spread to other parts of their body (metastasized).
Atherosclerotic narrowing and hardening of coronary arteries typically appear first at vessel branches, and a study in the October issue of Cellular Signalling reports that the type of mechanical stretching found at those branches activates a cellular protein known to damage cells.
A specific gene region has long been suspected of contributing to obesity in humans but the precise mechanisms behind this were previously unclear. Now, researchers at the Technical University of Munich (TUM), Massachusetts Institute of Technology (MIT), Harvard Medical School and other partners have been able to show that a single genetic alteration in this region reduces thermogenesis (fat burning), instead increasing lipid storage.
Pharmacyclics, Inc. today reported financial results and recent developments for the quarter and year ended December 31, 2013.
The East Tennessee Health Information Network (etHIN) has selected OptumInsight's health information exchange (HIE) technology to help physicians, hospitals and other health care providers in the region improve patient care coordination and quality.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Bruce Frederick Israel, MD 53 S French Broad Ave, Ste 200, Asheville, NC 28801-3272 Ph: (828) 258-9635 | Bruce Frederick Israel, MD 53 S French Broad Ave, Ste 200, Asheville, NC 28801-3272 Ph: (828) 258-9635 |
News Archive
The U.S. Food and Drug Administration today approved the first genetic test that can help some colorectal cancer (CRC) patients and their doctors determine if the drug Erbitux (cetuximab) would be an effective treatment based on the absence of a gene mutation. The therascreen KRAS RGQ PCR Kit can provide information about the KRAS gene mutation in patients whose CRC has spread to other parts of their body (metastasized).
Atherosclerotic narrowing and hardening of coronary arteries typically appear first at vessel branches, and a study in the October issue of Cellular Signalling reports that the type of mechanical stretching found at those branches activates a cellular protein known to damage cells.
A specific gene region has long been suspected of contributing to obesity in humans but the precise mechanisms behind this were previously unclear. Now, researchers at the Technical University of Munich (TUM), Massachusetts Institute of Technology (MIT), Harvard Medical School and other partners have been able to show that a single genetic alteration in this region reduces thermogenesis (fat burning), instead increasing lipid storage.
Pharmacyclics, Inc. today reported financial results and recent developments for the quarter and year ended December 31, 2013.
The East Tennessee Health Information Network (etHIN) has selected OptumInsight's health information exchange (HIE) technology to help physicians, hospitals and other health care providers in the region improve patient care coordination and quality.
› Verified 9 days ago
Dr. William R Harlan Iii, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 191 Biltmore Ave, Asheville, NC 28801 Phone: 828-254-0881 Fax: 828-254-1614 | |
Dr. Nellie E. L. Fleming, MD Infectious Disease Medicare: May Accept Medicare Assignments Practice Location: 509 Biltmore Ave, Asheville Hospitalist Group, Asheville, NC 28801 Phone: 828-213-4411 Fax: 828-285-9740 | |
Dr. Wade H Saunders Iii, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 5 Vanderbilt Park Dr, Asheville, NC 28803 Phone: 828-274-6000 Fax: 828-277-6350 | |
Marianne Soufas, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 68 Sweeten Creek Rd, Asheville, NC 28803 Phone: 828-274-9567 Fax: 828-255-2865 | |
Dr. Bryan J Pace, D.O. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 5 Vanderbilt Park Dr, Asheville, NC 28803 Phone: 828-274-6000 Fax: 828-274-6025 | |
Zachary Dillon Glenn, DO Infectious Disease Medicare: Medicare Enrolled Practice Location: 509 Biltmore Ave, Asheville, NC 28801 Phone: 828-213-1111 | |
Dr. Jeffrey Tyler Ramsey, DO Infectious Disease Medicare: Medicare Enrolled Practice Location: 123 Hendersonville Rd, Asheville, NC 28803 Phone: 828-407-2415 Fax: 828-412-4171 |